ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0G79 Syntheticmr Ab (publ)

350.00
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Syntheticmr Ab (publ) LSE:0G79 London Ordinary Share SE0015987946 SYNTHETICMR ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 350.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 89.21M 10.01M 0.2404 1,455.91 14.58B

SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D

30/11/2023 9:30am

PR Newswire (US)


Syntheticmr Ab (publ) (LSE:0G79)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Syntheticmr Ab (publ) Charts.

LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. 

The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be included in Philips' global price book once the relevant regulatory clearance has been obtained. This will enable Philips to offer the complete package to their customers.

"We are very excited to expand our collaboration with SyntheticMR, aiming to achieve greater results with fewer resources in the field of imaging," says Ruud Zwerink, GM at Philips Healthcare. "Through our partnership, we will provide clinicians and patients with improved, immediate, and distinctive insights that have a considerable impact on diagnosis, treatment planning, and the subsequent care – a previously elusive goal."

SyMRI 3D is a next-generation imaging solution with isotropic resolution that is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within SyMRI's post-processing solution. This advanced SyMRI 3D sequence introduces 3D resolution to quantitative values and tissue segmentations, ensuring the same level of precision in quantification as achieved with SyMRI's 2D imaging. 

SyMRI 3D enables precise volumetric estimations of brain regions, a technique commonly referred to as parcellation, which empowers clinicians to gain deeper insights into brain structure and function. Furthermore, the exceptional resolution provided by SyMRI 3D facilitates comprehensive lesion analysis, ensuring a more accurate and in-depth assessment of medical conditions.

"In joining forces with Philips on SyMRI 3D, we've achieved a pivotal milestone on our path to establishing a new standard in neuroimaging," says Ulrik Harrysson, CEO, SyntheticMR AB. "Our shared mission to enhance efficiency, elevate patient care, and drive meaningful savings in healthcare, reaffirms our commitment to revolutionize the field."

CONTACT:

For additional information, please contact Kyle Frye, CCO,  +1 (859) 512-9496 kyle.frye@syntheticmr.com

The following files are available for download:

https://mb.cision.com/Main/11663/3885483/2464711.pdf

Release

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/syntheticmr-and-philips-announce-expanded-global-partnership-for-symri-3d-302001799.html

Copyright 2023 PR Newswire

1 Year Syntheticmr Ab (publ) Chart

1 Year Syntheticmr Ab (publ) Chart

1 Month Syntheticmr Ab (publ) Chart

1 Month Syntheticmr Ab (publ) Chart